CHAMPIONS ONCOLOGY, INC. Stock-Based Compensation
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Stock-Based Compensation of $766.00 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-09-11
- CHAMPIONS ONCOLOGY, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-07-31 was $766.00K, a 268.27% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-04-30 was $357.00K, a 172.52% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-01-31 was $423.00K, a 65.23% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-10-31 was $249.00K, a 2666.67% increase year-over-year.
- CHAMPIONS ONCOLOGY, INC. share-based payment arrangement, noncash expense for fiscal 2026 was $1.24M, a 89.14% increase from fiscal 2025.
- CHAMPIONS ONCOLOGY, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $654.00K, a 41.50% decline from fiscal 2024.
- CHAMPIONS ONCOLOGY, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $1.12M, a 29.40% increase from fiscal 2023.
- CHAMPIONS ONCOLOGY, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $864.00K, a 5.26% decline from fiscal 2022.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-07-31 | $766.00K 10-Q · filed 2026-09-11 | $1.12M derived: sum of 2 quarters · filed 2026-09-11 | $1.55M derived: sum of 3 quarters · filed 2026-09-11 | $1.79M derived: sum of 4 quarters · filed 2026-09-11 |
| 2026-04-30 | $357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $780.00K derived: sum of 2 quarters · filed 2026-07-27 | $1.03M derived: sum of 3 quarters · filed 2026-07-27 | $1.24M 10-K · filed 2026-07-27 |
| 2026-01-31 | $423.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-12 | $672.00K derived: sum of 2 quarters · filed 2026-03-12 | $880.00K 10-Q · filed 2026-03-12 | $1.01M derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-10-31 | $249.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15 | $457.00K 10-Q · filed 2025-12-15 | $588.00K derived: sum of 3 quarters · filed 2026-09-11 | $844.00K derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-07-31 | $208.00K 10-Q · filed 2026-09-11 | $339.00K derived: sum of 2 quarters · filed 2026-09-11 | $595.00K derived: sum of 3 quarters · filed 2026-09-11 | $604.00K derived: sum of 4 quarters · filed 2026-09-11 |
| 2025-04-30 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-27 | $387.00K derived: sum of 2 quarters · filed 2026-07-27 | $396.00K derived: sum of 3 quarters · filed 2026-07-27 | $654.00K 10-K · filed 2026-07-27 |
| 2025-01-31 | $256.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-12 | $265.00K derived: sum of 2 quarters · filed 2026-03-12 | $523.00K 10-Q · filed 2026-03-12 | $786.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-10-31 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15 | $267.00K 10-Q · filed 2025-12-15 | $530.00K derived: sum of 3 quarters · filed 2025-12-15 | $909.00K derived: sum of 4 quarters · filed 2025-12-15 |
| 2024-07-31 | $258.00K 10-Q · filed 2025-09-15 | $521.00K derived: sum of 2 quarters · filed 2025-09-15 | $900.00K derived: sum of 3 quarters · filed 2025-09-15 | $953.00K derived: sum of 4 quarters · filed 2025-09-15 |
| 2024-04-30 | $263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-23 | $642.00K derived: sum of 2 quarters · filed 2025-07-23 | $695.00K derived: sum of 3 quarters · filed 2025-07-23 | $1.12M 10-K · filed 2025-07-23 |
| 2024-01-31 | $379.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | $432.00K derived: sum of 2 quarters · filed 2025-03-17 | $855.00K 10-Q · filed 2025-03-17 | $1.06M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-10-31 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-16 | $476.00K 10-Q · filed 2024-12-16 | $684.00K derived: sum of 3 quarters · filed 2024-12-16 | $1.01M derived: sum of 4 quarters · filed 2024-12-16 |
| 2023-07-31 | $423.00K 10-Q · filed 2024-09-13 | $631.00K derived: sum of 2 quarters · filed 2024-09-13 | $962.00K derived: sum of 3 quarters · filed 2024-09-13 | $1.08M derived: sum of 4 quarters · filed 2024-09-13 |
| 2023-04-30 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-19 | $539.00K derived: sum of 2 quarters · filed 2024-07-19 | $658.00K derived: sum of 3 quarters · filed 2024-07-19 | $864.00K 10-K · filed 2024-07-19 |
| 2023-01-31 | $331.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-15 | $450.00K derived: sum of 2 quarters · filed 2024-03-15 | $656.00K 10-Q · filed 2024-03-15 | $844.00K derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-10-31 | $119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-13 | $325.00K 10-Q · filed 2023-12-13 | $513.00K derived: sum of 3 quarters · filed 2023-12-13 | $823.00K derived: sum of 4 quarters · filed 2023-12-13 |
| 2022-07-31 | $206.00K 10-Q · filed 2023-09-13 | $394.00K derived: sum of 2 quarters · filed 2023-09-13 | $704.00K derived: sum of 3 quarters · filed 2023-09-13 | $838.00K derived: sum of 4 quarters · filed 2023-09-13 |
| 2022-04-30 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-24 | $498.00K derived: sum of 2 quarters · filed 2023-07-24 | $632.00K derived: sum of 3 quarters · filed 2023-07-24 | $912.00K 10-K · filed 2023-07-24 |
| 2022-01-31 | $310.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | $444.00K derived: sum of 2 quarters · filed 2023-03-16 | $724.00K 10-Q · filed 2023-03-16 | $885.00K derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-10-31 | $134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-13 | $414.00K 10-Q · filed 2022-12-13 | $575.00K derived: sum of 3 quarters · filed 2022-12-13 | $807.00K derived: sum of 4 quarters · filed 2022-12-13 |
| 2021-07-31 | $280.00K 10-Q · filed 2022-09-12 | $441.00K derived: sum of 2 quarters · filed 2022-09-12 | $673.00K derived: sum of 3 quarters · filed 2022-09-12 | $758.00K derived: sum of 4 quarters · filed 2022-09-12 |
| 2021-04-30 | $161.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | $393.00K derived: sum of 2 quarters · filed 2022-07-22 | $478.00K derived: sum of 3 quarters · filed 2022-07-22 | $598.00K 10-K · filed 2022-07-22 |
| 2021-01-31 | $232.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15 | $317.00K derived: sum of 2 quarters · filed 2022-03-15 | $437.00K 10-Q · filed 2022-03-15 | $600.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-10-31 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-13 | $205.00K 10-Q · filed 2021-12-13 | $368.00K derived: sum of 3 quarters · filed 2021-12-13 | $597.00K derived: sum of 4 quarters · filed 2021-12-13 |
| 2020-07-31 | $120.00K 10-Q · filed 2021-09-13 | $283.00K derived: sum of 2 quarters · filed 2021-09-13 | $512.00K derived: sum of 3 quarters · filed 2021-09-13 | $589.00K derived: sum of 4 quarters · filed 2021-09-13 |
| 2020-04-30 | $163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-26 | $392.00K derived: sum of 2 quarters · filed 2021-07-26 | $469.00K derived: sum of 3 quarters · filed 2021-07-26 | $600.00K 10-K · filed 2021-07-26 |
| 2020-01-31 | $229.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-15 | $306.00K derived: sum of 2 quarters · filed 2021-03-15 | $437.00K 10-Q · filed 2021-03-15 | $575.00K derived: sum of 4 quarters · filed 2021-03-15 |
| 2019-10-31 | $77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-14 | $208.00K 10-Q · filed 2020-12-14 | $346.00K derived: sum of 3 quarters · filed 2020-12-14 | $681.00K derived: sum of 4 quarters · filed 2020-12-14 |
| 2019-07-31 | $131.00K 10-Q · filed 2020-09-14 | $269.00K derived: sum of 2 quarters · filed 2020-09-14 | $604.00K derived: sum of 3 quarters · filed 2020-09-14 | $692.00K derived: sum of 4 quarters · filed 2020-09-14 |
| 2019-04-30 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-28 | $473.00K derived: sum of 2 quarters · filed 2020-07-28 | $561.00K derived: sum of 3 quarters · filed 2020-07-28 | $636.00K 10-K · filed 2020-07-28 |
| 2019-01-31 | $335.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-16 | $423.00K derived: sum of 2 quarters · filed 2020-03-16 | $498.00K 10-Q · filed 2020-03-16 | $654.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-10-31 | $88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-16 | $163.00K 10-Q · filed 2019-12-16 | $319.00K derived: sum of 3 quarters · filed 2019-12-16 | $456.00K derived: sum of 4 quarters · filed 2019-12-16 |
| 2018-07-31 | $75.00K 10-Q · filed 2019-09-16 | $231.00K derived: sum of 2 quarters · filed 2019-09-16 | $368.00K derived: sum of 3 quarters · filed 2019-09-16 | $515.00K derived: sum of 4 quarters · filed 2019-09-16 |
| 2018-04-30 | $156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-29 | $293.00K derived: sum of 2 quarters · filed 2019-07-29 | $440.00K derived: sum of 3 quarters · filed 2019-07-29 | $1.00M 10-K · filed 2019-07-29 |
| 2018-01-31 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-18 | $284.00K derived: sum of 2 quarters · filed 2019-03-18 | $848.00K 10-Q · filed 2019-03-18 | $1.61M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-10-31 | $147.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-17 | $711.00K 10-Q · filed 2018-12-17 | $1.47M derived: sum of 3 quarters · filed 2018-12-17 | $1.71M derived: sum of 4 quarters · filed 2018-12-17 |
| 2017-07-31 | $564.00K 10-Q · filed 2018-09-14 | $1.32M derived: sum of 2 quarters · filed 2018-09-14 | $1.56M derived: sum of 3 quarters · filed 2018-09-14 | $2.10M derived: sum of 4 quarters · filed 2018-09-14 |
| 2017-04-30 | $761.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-30 | $998.00K derived: sum of 2 quarters · filed 2018-07-30 | $1.53M derived: sum of 3 quarters · filed 2018-07-30 | $2.66M 10-K · filed 2018-07-30 |
| 2017-01-31 | $237.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $772.00K derived: sum of 2 quarters · filed 2018-03-19 | $1.90M 10-Q · filed 2018-03-19 | $2.41M derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-10-31 | $535.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-15 | $1.66M 10-Q · filed 2017-12-15 | $2.17M derived: sum of 3 quarters · filed 2017-12-15 | $2.74M derived: sum of 4 quarters · filed 2017-12-15 |
| 2016-07-31 | $1.13M 10-Q · filed 2017-09-14 | $1.64M derived: sum of 2 quarters · filed 2017-09-14 | $2.21M derived: sum of 3 quarters · filed 2017-09-14 | $2.95M derived: sum of 4 quarters · filed 2017-09-14 |
| 2016-04-30 | $509.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $1.08M derived: sum of 2 quarters · filed 2017-07-28 | $1.82M derived: sum of 3 quarters · filed 2017-07-28 | $2.60M 10-K · filed 2017-07-28 |
| 2016-01-31 | $567.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-17 | $1.31M derived: sum of 2 quarters · filed 2017-03-17 | $2.09M 10-Q · filed 2017-03-17 | $2.97M derived: sum of 4 quarters · filed 2017-03-17 |
| 2015-10-31 | $748.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-14 | $1.52M 10-Q · filed 2016-12-14 | $2.40M derived: sum of 3 quarters · filed 2016-12-14 | $3.06M derived: sum of 4 quarters · filed 2016-12-14 |
| 2015-07-31 | $775.00K 10-Q · filed 2016-09-14 | $1.65M derived: sum of 2 quarters · filed 2016-09-14 | $2.31M derived: sum of 3 quarters · filed 2016-09-14 | $3.13M derived: sum of 4 quarters · filed 2016-09-14 |
| 2015-04-30 | $878.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $1.53M derived: sum of 2 quarters · filed 2016-07-29 | $2.35M derived: sum of 3 quarters · filed 2016-07-29 | $3.16M 10-K · filed 2016-07-29 |
| 2015-01-31 | $657.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-16 | $1.48M derived: sum of 2 quarters · filed 2016-03-16 | $2.28M 10-Q · filed 2016-03-16 | $3.12M derived: sum of 4 quarters · filed 2016-03-16 |
| 2014-10-31 | $819.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-15 | $1.63M 10-Q · filed 2015-12-15 | $2.47M derived: sum of 3 quarters · filed 2015-12-15 | $3.41M derived: sum of 4 quarters · filed 2015-12-15 |
| 2014-07-31 | $808.00K 10-Q · filed 2015-09-11 | $1.65M derived: sum of 2 quarters · filed 2015-09-11 | $2.59M derived: sum of 3 quarters · filed 2015-09-11 | $3.06M derived: sum of 4 quarters · filed 2015-09-11 |
| 2014-04-30 | $839.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-29 | $1.78M derived: sum of 2 quarters · filed 2015-07-29 | $2.25M derived: sum of 3 quarters · filed 2015-07-29 | $2.81M 10-K · filed 2015-07-29 |
| 2014-01-31 | $940.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $1.42M derived: sum of 2 quarters · filed 2015-03-17 | $1.97M 10-Q · filed 2015-03-17 | $2.41M derived: sum of 4 quarters · filed 2015-03-17 |
| 2013-10-31 | $476.00K 10-Q · filed 2013-12-13 | $1.03M 10-Q · filed 2014-12-15 | $1.47M derived: sum of 3 quarters · filed 2014-09-12 | $2.04M derived: sum of 4 quarters · filed 2014-09-12 |
| 2013-07-31 | $552.00K 10-Q · filed 2014-09-12 | $994.00K derived: sum of 2 quarters · filed 2014-09-12 | $1.56M derived: sum of 3 quarters · filed 2014-09-12 | $2.19M derived: sum of 4 quarters · filed 2014-09-12 |
| 2013-04-30 | $442.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-28 | $1.01M derived: sum of 2 quarters · filed 2014-07-28 | $1.64M derived: sum of 3 quarters · filed 2014-07-28 | $2.38M 10-K · filed 2014-07-28 |
| 2013-01-31 | $570.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-14 | $1.19M derived: sum of 2 quarters · filed 2014-03-14 | $1.93M 10-Q · filed 2014-03-14 | $2.64M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-10-31 | $624.00K 10-Q · filed 2013-12-13 | $1.36M 10-Q · filed 2013-12-13 | $2.07M derived: sum of 3 quarters · filed 2013-12-13 | $2.82M derived: sum of 4 quarters · filed 2013-12-13 |
| 2012-07-31 | $739.00K 10-Q · filed 2013-09-13 | $1.45M derived: sum of 2 quarters · filed 2013-09-13 | $2.19M derived: sum of 3 quarters · filed 2013-09-13 | $3.05M derived: sum of 4 quarters · filed 2013-09-13 |
| 2012-04-30 | $711.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-26 | $1.46M derived: sum of 2 quarters · filed 2013-07-26 | $2.31M derived: sum of 3 quarters · filed 2013-07-26 | $3.32M 10-K · filed 2013-07-26 |
| 2012-01-31 | $744.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-13 | $1.60M derived: sum of 2 quarters · filed 2013-03-13 | $2.61M 10-Q · filed 2013-03-13 | $4.17M derived: sum of 4 quarters · filed 2013-03-13 |
| 2011-10-31 | $854.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-13 | $1.87M 10-Q · filed 2012-12-13 | $3.42M derived: sum of 3 quarters · filed 2012-12-13 | $4.63M derived: sum of 4 quarters · filed 2012-12-13 |
| 2011-07-31 | $1.01M 10-Q · filed 2012-09-12 | $2.57M derived: sum of 2 quarters · filed 2012-09-12 | $3.78M derived: sum of 3 quarters · filed 2012-09-12 | $3.98M derived: sum of 4 quarters · filed 2012-09-12 |
| 2011-04-30 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-18 | $2.77M derived: sum of 2 quarters · filed 2012-07-18 | $2.96M derived: sum of 3 quarters · filed 2012-07-18 | $3.13M 10-K · filed 2012-07-18 |
| 2011-01-31 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-14 | $1.41M derived: sum of 2 quarters · filed 2012-03-14 | $1.58M 10-Q · filed 2012-03-14 | |
| 2010-10-31 | $197.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-14 | $367.00K 10-Q · filed 2011-12-14 | ||
| 2010-07-31 | $170.00K 10-Q · filed 2011-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |